AstraZeneca Says DOJ Closing Probe Into Brilinta Trial
U.K. pharmaceutical giant AstraZeneca PLC said on Tuesday that it has received confirmation from the U.S. Department of Justice that it is closing its investigation into a clinical trial for the...To view the full article, register now.
Already a subscriber? Click here to view full article